- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Trastuzumab Deruxtecan (T-DXd) monotherapy
Total 281 results
-
Daiichi SankyoAstraZenecaRecruitingBreast CancerBelgium, Spain, Italy, China, Netherlands, United States, Portugal, Ireland, Brazil
-
Cancer Institute and Hospital, Chinese Academy...Not yet recruiting
-
National Cancer Center Hospital EastDaiichi Sankyo Co., Ltd.RecruitingGastric Adenocarcinoma | Gastroesophageal Junction AdenocarcinomaJapan
-
Ana C Garrido-Castro, MDAstraZeneca; Translational Breast Cancer Research ConsortiumRecruitingBreast Cancer | Metastatic Breast Cancer | HER2-low Breast CancerUnited States
-
Fudan UniversityNot yet recruitingBreast Cancer | Metastatic Breast CancerChina
-
Daiichi SankyoRecruitingHER2-positive Gastric Cancer | HER2-positive Gastroesophageal JunctionChina
-
Daiichi SankyoAstraZenecaRecruitingBreast Cancer | Advanced Solid TumorUnited States, Spain, Canada, France
-
Cancer Trials IrelandActive, not recruitingHER2-positive Breast CancerIreland
-
MedSIRDaiichi SankyoRecruitingBreast Cancer | Metastatic Breast CancerAustria, Spain
-
AstraZenecaDaiichi Sankyo Co., Ltd.CompletedGastric or Gastroesophageal Junction (GEJ) AdenocarcinomaChina
-
AstraZenecaRecruitingAdvanced Solid MalignanciesUnited States, Korea, Republic of, Spain, Australia, Sweden, Germany, United Kingdom
-
MedSIRNot yet recruitingAdvanced Breast Cancer | Hormone Receptor Positive Breast Carcinoma | Advanced Breast Carcinoma
-
Daiichi SankyoAstraZenecaRecruitingMetastatic Cancer | Advanced CancerSpain, Italy, United States, Korea, Republic of, Belgium, France, Israel, Australia, Japan, Taiwan, United Kingdom, Brazil
-
Daiichi SankyoRecruitingBreast Cancer | Advanced Cancer | HER2-positive Breast Cancer | HER2-low Breast CancerChina
-
Memorial Sloan Kettering Cancer CenterAstraZenecaRecruitingGlioblastoma | Brain Cancer | Metastatic Cancer | Recurrent Glioblastoma | Leptomeningeal MetastasisUnited States
-
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo CompanyRecruitingMetastatic Breast Cancer | Unresectable Breast Cancer | HER2-low Expressing Breast CancerAustria, Italy, Spain, Switzerland, Belgium, France, Denmark, Sweden, Norway
-
Daiichi SankyoCompletedHER2-positive Breast CancerSpain, Ireland, Italy
-
AstraZenecaDaiichi Sankyo Co., Ltd.RecruitingPart 1: Bladder, Biliary Tract, Cervical, Endometrial, Ovarian, Pancreatic Cancer, Rare Tumors, Any Tumor Type Excluding Breast, Gastric, Colorectal Cancer | Part 2: HER2 Expressing/Amplified Solid Tumors Excluding Breast, Gastric, Colorectal CancerAustralia, Korea, Republic of, Japan, Brazil, Canada, Taiwan, Thailand, United States, Italy, United Kingdom, Russian Federation, India, Belgium, Poland, Spain, Czechia, Netherlands
-
AstraZenecaDaiichi SankyoActive, not recruitingMetastatic Breast Cancer | HER2-positive Breast Cancer | Unresectable Breast Cancer | HER2-low Expressing Breast CancerCanada
-
AstraZenecaDaiichi Sankyo Co., Ltd.Active, not recruitingAdvanced Solid Tumors With HER2 Mutation,eg:Colorectal,Urothelial,Gastric, Hepatobiliary,Endometrial,Melanoma,Ovarian,Cervical,Salivary Gland,Pancreatic,BreastItaly, Spain, United States, France, Korea, Republic of, Japan, Canada, Denmark, Belgium
-
Daiichi SankyoAstraZeneca; NSABP Foundation Inc; German Breast Group; Spanish Breast Cancer Research...Active, not recruitingHER2-Positive Primary Breast Cancer | Residual Invasive Breast CancerUnited States, Spain, France, Germany, Korea, Republic of, United Kingdom, Denmark, Israel, Belgium, Taiwan, Chile, Italy, Japan, Peru, Portugal, China, Turkey, Canada, Ireland, Australia, Greece, Czechia, Singapore, Poland, Romania, Arge... and more
-
Daiichi SankyoRecruiting
-
Beijing 302 HospitalRecruiting
-
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo CompanyRecruitingHER2-positive Advanced Gastric Cancer | HER2-positive Gastroesophageal Junction AdenocarcinomaBelgium, Austria, Germany, Italy
-
AstraZenecaDaiichi SankyoCompletedHER2-mutant Non-Small Cell Lung CancerChina
-
Danish Breast Cancer Cooperative GroupNot yet recruitingMetastatic Breast Cancer | ER-positive Breast Cancer | Luminal B | Her2 Enriched | Basal Like
-
Daiichi SankyoRecruitingAdvanced Solid TumorJapan, United States, China
-
Daiichi SankyoMerck Sharp & Dohme LLCRecruitingGastric Cancer | Gastroesophageal Junction CancerJapan
-
Daiichi SankyoAstraZeneca; Daiichi Sankyo Co., Ltd.Active, not recruitingBreast CancerUnited States, Canada, Spain, Belgium, China, Italy, Korea, Republic of, Taiwan, Australia, Japan, Brazil, France, Germany, United Kingdom, Hong Kong
-
AstraZenecaDaiichi SankyoActive, not recruitingBreast Cancer; HER2-positive; MetastaticUnited States, Belgium, Canada, Denmark, Italy, Spain, Hungary, Taiwan, Turkey, France, Germany, Korea, Republic of, Brazil, India, Japan, Peru, Philippines, United Kingdom, China, South Africa, Israel, Russian Federation, Argentina, ... and more
-
Enliven TherapeuticsRecruitingHER2-positive Metastatic Breast Cancer | HER2 Gene Mutation | HER2 Mutant Non-small Cell Lung Cancer | HER2 AmplificationSpain, United States, Korea, Republic of, France, Taiwan, Italy, Australia
-
Seagen, a wholly owned subsidiary of PfizerActive, not recruitingHER2 Positive Breast CancerUnited States
-
Daiichi SankyoMerck Sharp & Dohme LLCRecruitingAdvanced Solid Tumor | Metastatic Solid TumorsJapan, United States
-
QuantumLeap Healthcare CollaborativeRecruitingSolid Tumor | Metastatic Cancer | Metastatic Breast Cancer | Triple Negative Breast Cancer | HER2-positive Breast Cancer | Solid Tumor, Adult | Solid Carcinoma | HER2-positive Metastatic Breast Cancer | Progesterone Receptor-positive Breast Cancer | HER2-negative Breast Cancer | Estrogen Receptor Positive... and other conditionsUnited States
-
Yonsei UniversityRecruitingGastric Cancer | Gastroesophageal Junction (GEJ) CancerKorea, Republic of
-
AstraZenecaDaiichi Sankyo Co., Ltd.RecruitingAdvanced Solid Tumors (Excluding Gastric Cancer and Breast Cancer)China
-
AstraZenecaDaiichi SankyoRecruitingLocally Advanced or Metastatic Non-Small Cell Lung CancerChina, Korea, Republic of, Germany, Italy, Poland, Belgium, Denmark, Mexico, Turkey, Spain, France, United States, Canada, Taiwan, Brazil, Hong Kong, India, Austria, Japan, Netherlands
-
Daiichi SankyoAstraZenecaAvailableEGFRm Advanced Non-Small Cell Lung Cancer | EGFRm Metastatic Non-Small Cell Lung CancerUnited States
-
Daiichi SankyoMerck Sharp & Dohme LLCNot yet recruiting
-
Daiichi SankyoMerck Sharp & Dohme LLCRecruitingAdvanced Solid Tumor | Malignant Solid TumorUnited States, Japan
-
Merck Sharp & Dohme LLCDaiichi SankyoRecruitingGastrointestinal CancerUnited States, Hong Kong, Spain
-
Daiichi SankyoMerck Sharp & Dohme LLCRecruitingRecurrent or Metastatic Solid TumorsTaiwan, Spain, Belgium, Germany, Japan, Italy, Mexico, Netherlands, France, Poland, Ireland, Australia, United States, Portugal, Argentina, Turkey, Chile, Brazil
-
Jeeyun LeeRecruitingStomach NeoplasmKorea, Republic of
-
AstraZenecaDaiichi SankyoRecruitingLocally Advanced or Metastatic Non-Small Cell Lung CancerKorea, Republic of, Philippines, Italy, Poland, Malaysia, Taiwan, Thailand, United States, France, Canada, Singapore, Spain, Turkey, Australia, Belgium, Israel, Netherlands
-
Merck Sharp & Dohme LLCDaiichi SankyoNot yet recruiting
-
Institut für Klinische Krebsforschung IKF GmbH...Daiichi SankyoRecruiting
-
AstraZenecaDaiichi SankyoActive, not recruitingBreast CancerBelgium, Denmark, Finland, Italy, Norway, Spain, Sweden, Poland, United States, Canada, Germany, Japan, Netherlands, Portugal, Switzerland, Australia, United Kingdom, Ireland
-
Daiichi SankyoBristol-Myers Squibb; AstraZenecaCompletedBreast Cancer | Urothelial CarcinomaUnited States, Spain, Italy, Belgium, France, Germany, United Kingdom
-
Dana-Farber Cancer InstituteJohns Hopkins University; Translational Breast Cancer Research ConsortiumRecruitingBreast Cancer | HER2-positive Breast Cancer | Stage IV Breast Cancer | Breast Cancer Female | Breast Cancer Metastatic | Estrogen Receptor-positive Breast CancerUnited States
-
Daiichi SankyoMerck Sharp & Dohme LLCActive, not recruitingExtensive-stage Small-cell Lung CancerUnited States, Germany, Spain, China, Korea, Republic of, France, Taiwan, Japan